Senseonics SENS 深 沪
已收盘 10-16 16:00:00 美东时间
7.77
-0.460
-5.59%
华盛通- 最 高8.23
- 今 开8.23
- 成交量 60.91万股
- 最 低 7.75
- 昨 收 8.23
- 总市值 4.11亿
- 52周最高 10.64
- 市盈率 静 --
- 换手率 1.15%
- 52周最低 4.79
- 委 比 -62.11%
- 总股本 5287.41万
- 历史最高 111.20
- 量 比 1.06
- 振 幅 5.83%
- 历史最低 4.79
- 每 手 1
- 风险率 1.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript
Senseonics Holdings (AMEX:SENS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a con...
10-12 19:18
估值跌至十年低点！巴克莱首次覆盖26家美股医疗科技股，首选史赛克(SYK.US)等
巴克莱分析师Christopher Pasquale周二首次覆盖26家美股医疗科技公司，并将史赛克(SYK.US)和雅培(ABT.US)列入大盘医疗科技股推荐名...
10-08 13:58
美股大行评级 | 潜在涨幅175.74%！美光科技获DA Davidson上调目标价至3000美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持美光科技"买入"评级，目标价从2100美元升至3000美元；Leerink Partners：维持OmniAb"跑赢大市"评级，目标价从10美元升至12美元
10-08 12:30
Barclays Initiates Coverage On Senseonics Holdings with Equal-Weight Rating, Announces Price Target of $10
Barclays analyst Christopher Pasquale initiates coverage on Senseonics Holdings (NASDAQ:SENS) with a Equal-Weight rating and announces Price Target of $10.
10-07 21:11
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics’ Eversense® 365
Beta Bionics announced a partnership with Senseonics to integrate the iLet Bionic Pancreas and mint AID systems with Senseonics’ Eversense 365 CGM system. The integrated system is expected to launch in Q4 2026, offering users the most CGM manufacturer options for AID systems. The collaboration aims to expand reach and maximize choice for people with diabetes, combining advanced adaptive AID technology with long-term glucose sensing.
09-22 11:30
Senseonics Partners With Beta Bionics To Integrate Its Eversense 365 CGM With Beta Bionics’ iLet Bionic Pancreas Automated Insulin Delivery System
The companies are collaborating to integrate Eversense® 365 CGM with Beta Bionics’ iLet® Bionic Pancreas automated insulin delivery (AID) system designed to simplify diabetes management. The integrated device will aim to provide people with diabetes a world-class, truly differentiated AID experience...
09-14 19:05
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
Senseonics and Beta Bionics collaborate to integrate Eversense 365 CGM with iLet Bionic Pancreas for enhanced diabetes management. The combined system aims to simplify insulin delivery and glucose monitoring, offering a year-long sensing solution without carb counting. Commercial launch planned for Q4 2026.
09-14 11:00
Senseonics To Participate in Upcoming Institutional Investor Conferences
Senseonics Holdings, Inc. announced its participation in two upcoming investor conferences in September 2026: the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference on September 10 and the H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, both in New York. The company will host one-on-one meetings with investors and present its CGM systems, Eversense® 365 and Eversense® E3, which provide long-term gluco...
09-10 12:00
These low-priced stocks are flashing overbought signals
Several sub-$10 stocks are flashing elevated momentum signals, with a handful already entering traditionally overbought territory as recent rallies push their Relative Strength Index readings toward t...
09-05 00:19
e.l.f., Senseonics, Dropbox, 3D Systems, Nucor Shake Markets
Insiders have been trading these 5 stocks: (($ELF)), (($SENS)), (($DBX)), (($DD...
08-22 21:01
